Composition Epirubicin (50mg)
Shipping class Cold
Primary Use Ovarian cancer, Breast cancer, Non-small cell lung cancer
cautionPotentially unsafe with Alcohol Lactation
Medicine Overview of Alrubicin Injection
Uses of Alrubicin Injection
Alrubicin 50mg Injection is used in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer and stomach cancer.
Alrubicin Injection side effects
Nausea, Vomiting, Loss of appetite, Low blood platelets, Hair loss, Anemia (low number of red blood cells), Diarrhoea, Discoloration of urine, Mucosal inflammation, Stomatitis (Inflammation of the mouth), Febrile neutropenia, Decreased white blood cell count (neutrophils).
How to use Alrubicin Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How Alrubicin Injection works
Alrubicin 50mg Injection is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.
In Depth Information on Alrubicin Injection
Expert advice for Alrubicin Injection
- Use appropriate contraception during treatment with epirubicin, if you are women of childbearing potential.
- Male patients should not to father a child during and for 6 months after stopping epirubicin treatment.
- Inform you doctor if you have or had suffered problems with your heart, liver or if you have severe infection such as urinary infection.
- Do not drink fluids for 12 hours before the treatment if epirubicin is to be used in the bladder.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Alrubicin Injection related warnings
Special precautions for Alrubicin Injection
Taking Epirubicin together with alcohol may cause liver problems.
WEIGH RISKS VS BENEFITS
Alrubicin 50mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Alrubicin 50mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Do not drive unless you are feeling well. Alrubicin 50mg Injection may cause episodes of nausea and vomiting, which can temporarily lead to an impairment of the ability to drive.
Alrubicin 50mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Alrubicin 50mg Injection may not be needed in these patients. Please consult your doctor. Lower doses may be considered in patients with serum creatinine > 5 mg/dL.
Alrubicin 50mg Injection should be used with caution in patients with liver disease. Dose adjustment of Alrubicin 50mg Injection may be needed. Please consult your doctor. Use of Alrubicin 50mg Injection is not recommended in patients with severe liver disease.